Last updated on: 07/08/2019
1. Contact details
Name of data sourceThe Health Improvement Network
Name under which the data source should be displayed in the inventory (e.g short name if one exists)THIN
Name of organisation
1) Department/research groupTHIN
2) Organisation/affiliationCegedim
Administrative Contact
Title Mr
Last name Dhalla
First name Samir
Address line 1The Bread Factory
Address line 21a Broughton street
Address line 3Battersea
CityLondon
PostcodeSW8 3QJ
CountryUnited Kingdom
Scientific Contact
Title Mr
Last name Dhalla
First name Samir
Address line 1The Bread Factory
Address line 21a Broughton street
Address line 3Battersea
CityLondon
PostcodeSW8 3QJ
CountryUnited Kingdom
Alternative Contact
Title Ms
Last name Jessop
First name Shelley
Address line 1The Bread Factory
Address line 21a Broughton street
Address line 3Battersea
CityLondon
PostcodeSW8 3QJ
CountryUnited Kingdom
2. Description/category
Routine primary care electronic patient registry
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
Vaccines
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
SafeScript
3.4 Recording of indication for use
Yes
Is a coding dictionary being used? READ
4. Coverage of events
Event
Dictionary
Dictionary details
Adverse events (for pharmacovigilance databases)
Yes
READ
Symptoms/signs
Yes
READ
Diagnosis in primary care
Yes
READ
Specialist diagnosis
Yes
READ
Discharge diagnosis
Yes
READ
Laboratory values
Yes
Database specific
Death
Yes
READ
Procedures
Yes
READ
Overdoses
Yes
READ
Teratogenic events
Yes
READ
5. Year of establishment
2002
6. Geographical origin of data
EEA/EFTA countries
Belgium
France
Romania
Spain
United Kingdom
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
18 to 45 years
46 to 64 years
65 years and over
9. Size of the source/catchment population
60,000,000
10 a. Total (cumulative) number of persons with actual data
12,400,000
10 b. Number of persons with active data collection in past calendar year
3,700,000
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
Yes
b) Questionnaire data from the patient?
Yes
c) Genetic information or samples?
Yes
12. Possibility of links to other sources of data
Yes :
Linked upon Request
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
Cederholm S1, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K, Norén GN.
Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y.http://www.ncbi.nlm.nih.gov/pubmed/25539877
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study.
Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G, Lipscombe LL.
Diabetologia. 2013 Jun 22. http://link.springer.com/article/10.1007%2Fs00125-013-3063-1
Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis. Wijlaars LP1, Nazareth I, Whitaker HJ, Evans SJ, Petersen I. BMJ Open. 2013 Sep 19;3(9):e003247. doi: 10.1136/bmjopen-2013-003247.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780295/
